Schedule:

• 12 - 12:30 p.m.
  Alzheimer's Disease and Novel Drug Therapy
  Presented By: Radhika Rani, DO


• 12:30 - 1 p.m.
  The Psychiatric Manifestations of Brain Tumors
  Presented By: Christine Emmanuel, DO

Learning Objectives

• Recognize the clinical signs and patient presentation of Alzheimer's disease
• Discuss current management approaches as well as upcoming research in Alzheimer's disease treatment
• Apply the information presented on aducanumab to patient care
• Describe how brain tumors can manifest with psychiatric symptoms in the absence of or preceding focal neurological signs
• Explain the importance of the early diagnosis of brain tumors and recognizing atypical psychiatric symptoms as presenting features
• Recognize when neuroimaging is indicated for patients presenting with psychiatric symptoms

Accredidation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicans.

Accredidation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure
The course director and members of the planning committee do not have any relevant financial relationships with any commercial interests to disclose regarding today's presentation.

Faculty and all others who have ability to control the content of continuing medical education activities sponsored by Tower Health are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Christine Emmanuel, DO and Radhika Rani, DO have no relevant financial relationship﴾s﴿ with ineligible companies whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients to disclose.